Press Release

Digital Pathology Market to witness a CAGR of 13.5% by 2026; Increasing demand for Reliable Diagnostic Techniques for Chronic Disease Identification to stimulate the Market Growth
May 2021

Digital Pathology Market to witness a CAGR of 13.5% by 2026; Increasing demand for Reliable Diagnostic Techniques for Chronic Disease Identification to stimulate the Market Growth

The global Digital Pathology Market is valued at USD 931.5 million in 2020 and is expected to grow at a CAGR of 13.5% by 2026, according to a new research report by iCognition Insights Pvt. Ltd. This global report on Digital Pathology focuses on market size and forecast at global, segmental, regional and country level providing an end-to-end market overview of the industry segment for period 2020-2026. The report further delivers key insights on the historical market size, market drivers, restraints, future opportunities, and market dynamics driving the growth by 2026. iCognition Insights have analyzed the competition- key market leaders and new market entrants offering deep-dive intelligence on their strategies and market approaches, mergers and acquisitions, disruptive technologies which could alter or change the entire market trend.

Digital pathology is a dynamic image-based environment that acquires, manages, and interprets pathology information generated from digital slides. When a scanning device is used to capture a slide, a digital slide is created to provide a high-resolution image that can be viewed on a computer screen or mobile device. Its healthcare applications include primary diagnosis, clinical research, intraoperative diagnosis, diagnostic consultation, training of medical students, diagnostic decision support etc. Whereas in life science, the applications include quantitative analysis of slide images, high throughput glass slide scanning, instant online consultation with professional pathologists, and secure archiving of pathology data. At present, it is one of the most promising fields in diagnostic medicine for achieving accurate and speedier diagnosis, increasing productivity and better treatment decisions and reducing laboratory costs. Increasing prevalence of chronic conditions is expected to surge clinical urgency for adopting quicker and reliable diagnostic techniques, stimulating the growth of global digital pathology market. Additionally, rising geriatric population with higher tendency of chronic disease susceptibility is fostering the demand for digital pathology technologies. As per National Council on Aging (NCOA), around 80% of the older adults have at least one chronic disease in U.S. out of which 68.4% of the Medicare beneficiaries consists of two or more chronic diseases whereas 36.4% have four or more. However, the expensive digital system integration in pathology is the major factor restraining the global market growth.

Request for a detailed market summary, research scope and table of contents @ Digital Pathology Market: Report Sample

The Digital Pathology Market is segmented based on Product (Device, Software, and Storage system), by Application (Academic research, Drug discovery & Development, and Diagnosis), by End User (Academic & research institutes, Diagnostic labs, Hospitals, and Biotech & pharma companies) and by Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Global Digital Pathology Market Share Analysis:

  • In 2020, the device product segment accounted for the significant revenue share due to increase in research and development activities coupled with improved resolution worldwide. The software segment is projected to grow at a lucrative CAGR during the forecast period to 2026 owing to the increasing technological advancements with improved outcomes.
  • The academic research application segment accounted for the highest revenue share in 2020 and is projected to maintain its dominance over the forecast period owing to the broad applications of digital technology in various research studies.
  • The hospitals end user segment held the highest market share in 2020 and is expected to maintain its dominance during the forecast period due to significant improvement in adoption of digital scanning for quicker and reliable diagnosis. The biotech and pharma companies’ segment is anticipated to grow at a substantial CAGR during the forecast period with surge in application of digital scanning technology in oncology clinical trial and preclinical GLP pathology.
  • North America accounted for the highest revenue share in 2020 and is projected to maintain its dominance during the forecast period due to high per capita healthcare expenditure and extensive technology investments in novel innovations in this region. According to Organization for Economic Co-operation and Development (OECD), the U.S. healthcare spending was a staggering USD 11,072 per capita in 2019 and is expected to surge even higher in the future.
  • Asia Pacific is expected to have the fastest CAGR over the forecast period owing to the strengthening digital technology in the region, high government support and growing demand for improved and reliable diagnostic results.

Key Industry Developments:

  • October 2020: Indica Labs announced the launch of enterprise-wide, cloud-based digital pathology at National Cancer Institute NCI in Albuquerque, NM.
  • June 2019: Royal Philips, a global leader in health technology, partnered with Alverno Laboratories, a provider of high-quality diagnostic testing services, allowing Alverno to implement digital pathology in its clinical laboratories for assessing and diagnosing all clinical histology cases digitally.

Key Leading Companies Profiled in the Digital Pathology Market Analysis Report:

This exhaustive research report analyzes 10 global companies that are adopting innovative technologies and approaches to gain maximum market share.

  • 3DHISTECH Kft. (Hungary)
  • DigiPath, Inc. (U.S.)
  • AstraZeneca plc (U.K.)
  • Inspirata Inc. (U.S.)
  • Mikroscan Technologies (U.S.)
  • Hoffmann-La Roche AG (Switzerland)
  • Olympus Corporation (Japan)
  • Koninklijke Philips N.V. (Netherlands)
  • Hamamatsu Photonics K.K. (Japan)
  • Danaher Corporation (U.S.)

Research Scope and Market Segmentation of Digital Pathology Report:

Key Parameters Details
Analysis Period 2018-2026
Historical Period 2018-2020
Forecast Period 2020-2026
Segmentation Product, Application, and End User
Based on Product
  • Device
    • Scanners
    • Slide Management System
  • Software
  • Storage System
Based on Application
  • Academic Research
  • Drug Discovery & Development
  • Diagnosis
    • Cancer Cell Detection
    • Others
Based on End User
  • Academic & Research Institutes
  • Diagnostic Labs
  • Hospitals
  • Biotech & Pharma Companies
Based on Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Express buy the full report @ Purchase Report: Checkout